Immunotherapies in Neurologic Disorders

Donna Graves, Steven Vernino

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations


Therapy for autoimmune demyelinating disorders has evolved rapidly over the past 10 years to include traditional immunosuppressants as well as novel biologicals. Antibody-mediated neuromuscular disorders are treated with therapies that acutely modulate pathogenic antibodies or chronically inhibit the humoral immune response. In other inflammatory autoimmune disorders of the peripheral and central nervous system, corticosteroids, often combined with conventional immunosuppression, and immunomodulatory treatments are used. Because autoimmune neurologic disorders are so diverse, evidence from randomized controlled trials is limited for most of the immunotherapies used in neurology. This review provides an overview of the immunotherapies currently used for neurologic disorders.

Original languageEnglish (US)
Pages (from-to)497-523
Number of pages27
JournalMedical Clinics of North America
Issue number3
StatePublished - May 1 2012


  • Autoimmune encephalopathy
  • Intravenous immunoglobulin
  • Multiple sclerosis
  • Myasthenia gravis
  • Neuromyelitis optica
  • Paraneoplastic neurologic disorders

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Immunotherapies in Neurologic Disorders'. Together they form a unique fingerprint.

Cite this